Cite
APA Citation
Beuschlein, F., Jakoby, J., Mentz, S., Zambetti, G., Jung, S., Reincke, M., Süss, R., & Hantel, C. (2016). iGF1-R inhibition and liposomal doxorubicin: Progress in preclinical evaluation for the treatment of adrenocortical carcinoma. Molecular and cellular endocrinology, 428, 82–88. http://access.bl.uk/ark:/81055/vdc_100032061603.0x00002f